Company news

Gossamer Bio, Inc. news in 2023

Gossamer Bio, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Gossamer Bio to Host Webcast to Discuss Latest Seralutinib Open-Label Extension Data on December 18, 2023

December 12, 2023

Gossamer Bio Appoints Bob Smith as Chief Commercial Officer

December 4, 2023

Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors

November 28, 2023

Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update

November 8, 2023

Gossamer Bio Announces Addition of Rainer Zimmermann, MD, as VP of Medical Affairs

October 2, 2023

Gossamer Bio to Present Results of TORREY FRI Sub-Study at the European Respiratory Society International Congress 2023

September 6, 2023

Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update

August 7, 2023

Gossamer Bio to Hold Conference Call with PAH Experts to Discuss PROSERA Phase 3 Design and Interim TORREY OLE Results

July 23, 2023

Gossamer Bio Announces $212 Million Private Placement Financing

July 19, 2023

Gossamer Bio Announces TORREY Data to be Featured at American Thoracic Society 2023 International Conference

May 17, 2023

Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update

May 8, 2023

Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update

March 16, 2023

Decks in 2023